NCT00901836

Preoperative Proton Radiotherapy for Retroperitoneal Sarcoma

A Pilot Study Investigating Preoperative Proton Radiotherapy for Retroperitoneal Sarcoma

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 2 (actual)
• Sponsor: University of Florida · Academic / Other
• Sex: Male
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The goal of this study is to evaluate radiation treatment intended to increase the chance of curing your sarcoma and decrease the side effects of proton therapy. This study will also look at the tumor tissue that was removed during your initial biopsy and your final surgery for information that may help to treat retroperitoneal sarcoma in the future.

Detailed description

Data collection will be obtained from the patient's medical records including initial evaluation, pathology report, dosimetry information, radiotherapy completion records and follow-up.

Conditions

• Retroperitoneal Sarcoma

Interventions

Type	Name	Description
RADIATION	Preoperative proton therapy	28 daily fractions of 1.8 cobalt gray equivalent(CGE)/fx for total of 50.4 CGE over 5.5 weeks.
PROCEDURE	Surgery	Standard of care surgery will be performed 4-6 weeks after completion of radiation.

Timeline

• Start date: 2009-05-01
• Primary completion: 2012-11-01
• Completion: 2012-11-01
• First posted: 2009-05-14
• Last updated: 2017-02-10

Locations

1 site across 1 country: United States